BNP PARIBAS ASSET MANAGEMENT Holding S.A.

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1520354 Paris, I0

Position in RARE

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$8,760,221

-$34,931,982 QoQ

Shares Held

418,149

-78.0% QoQ

Ownership

0.425%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

11 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $2,095,512,918 across 139 Biotechnology names. RARE ranks #31 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	848,047	$378,686,906
2	REGN	Regeneron Pharmaceuticals, Inc.	273,120	$211,023,436
3	JAZZ	Jazz Pharmaceuticals plc	885,201	$167,347,247
4	ARGX	Argenx SE	129,147	$94,309,595
5	INCY	Incyte Corp	938,848	$88,364,372
6	XENE	Xenon Pharmaceuticals Inc.	1,342,028	$78,038,926
7	INSM	INSMED Inc	467,753	$76,486,969
8	IONS	Ionis Pharmaceuticals Inc	907,533	$68,146,652

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,760,221	418,149	-78.0%	Shares	Defined	2026-05-14
2025-12-31	$43,692,203	1,899,661	+22.9%	Shares	Defined	2026-02-13
2025-09-30	$46,481,991	1,545,279	+6.4%	Shares	Defined	2025-11-07
2025-06-30	$52,799,446	1,452,130	+26.2%	Shares	Defined	2025-08-06
2025-03-31	$41,658,011	1,150,456	+20.1%	Shares	Defined	2025-05-14
2024-12-31	$40,306,298	958,077	+32.3%	Shares	Defined	2025-02-12
2024-09-30	$40,228,309	724,182	-12.8%	Shares	Defined	2024-11-08
2024-06-30	$34,128,412	830,375	+63.8%	Shares	Defined	2024-07-30
2024-03-31	$23,676,265	507,095	+513.8%	Shares	Defined	2024-05-08
2023-12-31	$3,950,840	82,619	+915.1%	Shares	Defined	2024-02-09
2022-06-30	$485,572	8,139	—	Shares	Defined	2022-08-04
No filing history on record for this holder in this stock.